Q2 2024 |
13 |
$238M |
+$21.9M |
-$26.6M |
-$4.67M |
BLBD, ATRO, BTMD, ASTH, APEI
|
13F-HR |
8/14/2024, 04:00 PM |
Q1 2024 |
12 |
$217M |
+$710K |
-$6.75M |
-$6.04M |
BLBD, ATRO, SGOV, ASTH, BTMD
|
13F-HR |
5/15/2024, 04:00 PM |
Q4 2023 |
13 |
$202M |
+$61.3M |
-$6.25M |
+$55.1M |
BLBD, ATRO, SGOV, ASTH, BTMD
|
13F-HR |
2/14/2024, 04:00 PM |
Q3 2023 |
8 |
$121M |
+$6.13M |
-$18.6M |
-$12.4M |
ATRO, BLBD, BTMD, ASTH, MPAA
|
13F-HR |
11/14/2023, 04:01 PM |
Q2 2023 |
9 |
$152M |
+$23.7M |
$0 |
+$23.7M |
ATRO, BLBD, BTMD, NXGN, ASTH
|
13F-HR |
8/14/2023, 04:01 PM |
Q1 2023 |
9 |
$114M |
+$15.7M |
$0 |
+$15.7M |
BLBD, ATRO, NXGN, ASTH, BTMD
|
13F-HR |
5/15/2023, 04:01 PM |
Q4 2022 |
7 |
$92.3M |
+$258K |
-$517K |
-$260K |
NXGN, ATRO, BLBD, MPAA, APEI
|
13F-HR |
2/14/2023, 04:04 PM |
Q3 2022 |
8 |
$85.7M |
+$16.1M |
-$29.3M |
-$13.2M |
NXGN, MPAA, ASTH, ATRO, BLBD
|
13F-HR |
11/14/2022, 04:01 PM |
Q2 2022 |
10 |
$108M |
+$9.78M |
-$5.83M |
+$3.96M |
NXGN, APEI, ATRO, MPAA, BLBD
|
13F-HR |
8/15/2022, 04:00 PM |
Q1 2022 |
9 |
$132M |
+$42.8M |
-$15.2M |
+$27.6M |
NXGN, BLBD, APEI, MPAA, ATRO
|
13F-HR |
5/16/2022, 04:00 PM |
Q4 2021 |
9 |
$102M |
$0 |
$0 |
|
NXGN, LRN, MPAA, ATRO, APEI
|
13F-HR |
2/14/2022, 04:07 PM |